Composite Cardiovascular Risk Scores and Neuropsychological Functioning: A Meta-Analytic Review

Annals of Behavioral Medicine

Volumn 49, Issue 3, 2015, Pages 344-357

  DeRight, Jonathan ^a,b   Jorgensen, Randall S ^a   Cabral, Misaell J ^a  

^a SYRACUSE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Aging; Cardiovascular diseases; Epidemiology; Meta analysis; Risk factors

Indexed keywords

CARDIOVASCULAR DISEASES; COGNITION DISORDERS; HUMAN; META ANALYSIS; NEUROPSYCHOLOGICAL TEST; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA;

CARDIOVASCULAR DISEASES; COGNITION DISORDERS; HUMANS; NEUROPSYCHOLOGICAL TESTS; RISK ASSESSMENT;

EID: 84939955911     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-014-9681-0     Document Type: Article

References (71)

1. Bursi F, Rocca WA, Killian JM, et al. Heart disease and dementia: A population-based study. Am J Epidemiol. 2005; 163(2): 135-141. doi:10.1093/aje/kwj025.
2. Centers for Disease Control. Summary health statistics for U.S. Adults: National Health Interview Survey, 2010. Vital and Health Statistics, Series 10, 2012; (Number 252).
3. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2012 update: A report from the American heart association. Circulation. 2012; 125(1): e2-e220. doi:10.1161/CIR.0b013e31823c046.
4. Alzheimer’s Association, 2012. 2012 Alzheimer’s Disease facts and figures. Retrieved from http://www.alz.org/downloads/facts_figures_2012.pdf
5. Hachinski V. Stroke and vascular cognitive impairment: A transdisciplinary, translational, and transactional approach. Stroke. 2007; 38: 1396-1403. doi:10.1161/01.STR.0000260101.08944.e9.
6. * Laughlin GA, McEvoy LK, von Mühlen D, et al. Sex differences in the association of Framingham Cardiac Risk Score with cognitive decline in community-dwelling elders without clinical heart disease. Psychosom Med. 2011; 73: 683-689. doi:10.1097/PSY.0b013e31822f9089.
7. Ettorre E, Fossati C, Marigliano B, et al. Role of cardiovascular risk factors (cardiovascular risk factor) in the patients with mild cognitive impairment (MCI). Arch Gerontol Geriatr. 2012; 54(2): 330-332. doi:10.1016/j.archger.2011.04.025.
8. Román GC. Vascular dementia prevention: A risk factor analysis. Cerebrovasc Dis. 2005; 20(suppl 2): 91-100. doi:10.1159/000089361.
9. * Kaffashian S, Dugravot A, Nabi H, Batty GD, Brunner E, Kivimäki M, Singh-Manoux A. Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: Evidence from the Whitehall II study. Eur Heart J. 2011; 32: 2326–2332. doi: 10.1093/eurheartj/ehr122.
10. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003; 22: 13-22. doi:10.1159/000067109.
11. * Elias MF, Sullivan LM, D’Agonstino RB, et al. Framingham stroke risk profile and lowered cognitive performance. Stroke. 2004; 35: 404-409. doi:10.1161/01.STR.000103141.82869.77.
12. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011; 77: 461-468.
13. Ciobica A, Padurariu M, Bild W, et al. Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer’s disease. Psychiatr Danub. 2011; 23(4): 340-346.
14. Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume, and cognitive function: The Framingham offspring study. Neurology. 2004; 63: 1591-1599.
15. Elias MF, Elias PK, Sullivan LM, et al. Obesity, diabetes and cognitive deficits: The Framingham heart study. Neurobiol Aging. 2005; 26S: S11-S16. doi:10.1016/j.neurobiolaging.2005.08.019.
16. * Llewellyn DJ, Lang IA, Xie J, Huppert FA, Melzer D, Langa KM. Framingham Stroke Risk Profile and poor cognitive function: A population-based study. BMC Neurol. 2008; 8 (12). doi:10.1186/147-2377-8-12
17. Li J, Wang YJ, Zhang M, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011; 76: 1485-1491.
18. van Dijk EJ, Prins ND, Vrooman HA, et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam scan study. Stroke. 2008; 39: 2712-2719. doi:10.1161/STROKEAHA.107.513176.
19. Kivipelto M, Helkala EL, Hänninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology. 2001; 56: 1683-1689.
20. Seux ML, Thijs L, Forette F, et al. Correlates of cognitive status of old patients with isolated systolic hypertension: the Syt-Eur vascular Demenia project. J Hypertens. 1998; 16: 963-969.
21. Farmer ME, White LR, Abbott RD, et al. Blood pressure and cognitive performance. The Framingham study. Am J Epidemiol. 1987; 126(6): 1103-1114.
22. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008; 4(2): 363-381.
23. * Zade D, Beiser A, McGlinchey R, Au R, Seshadri S, Palumbo C, Wolf PA, DeCarli C, Milberg W. Interactive Effects of Apolipoprotein E Type 4 Genotype and Cerebrovascular Risk on Neuropsychological Performance and Structural Brain Changes. J Stroke Cerebrovasc Dis. 2010; 19 (4):261–268. doi:10.1016/j.jstrokecerebrovasdis.2009.05.001
24. Knopman DS, Mosley TH, Catellier DJ, et al. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study. Alzheimers Dement. 2009; 5: 207-214. doi:10.1016/j.jalz.2009.01.027.
25. Knopman D, Boland LL, Mosley T, et al. Atherosclerosis risk in communities (ARIC) study investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001; 56: 42-48.
26. Birns J, Kalra L. Cognitive function and hypertension. J Hum Hypertens. 2009; 23: 86-96. doi:10.1038/jhh.2008.80.
27. Maineri NL, Xavier FM, Berleze MC, et al. Risk factors for cerebrovascular disease and cognitive function in the elderly. Arq Bras Cardiol. 2007; 89(3): 142-146.
28. Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of hippocampus with ageing. Nat Rev Neurol. 2012; 8(4): 189-202. doi:10.1038/nrneurol.2012.27.
29. Wadley VG, McClure LA, Howard VJ, et al. Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2007; 38: 1143-1147. doi:10.1161/01.STR.0000259676.75552.38.
30. Starr JM, Deary IJ, Inch S, et al. Age-associated cognitive decline in healthy old people. Age Ageing. 1997; 26: 295-300.
31. Panza F, D’Introno A, Colacicco AM, et al. Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiol Aging. 2006; 27(7): 933-940. doi:10.1016/j.neurobiolaging.2005.05.008.
32. * Smith PJ, Blumenthal JA, Babyak MA, Benson MH, Doraiswamy M, Waugh R, Hinderliter A, Sherwood A. Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. Psychosom Med. 2007; 69 (6):578–586. doi:10.1097/PSY.0b013e31812f7b8e
33. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet. 1997; 349: 151-154.
34. van Oijen M, Jan de Jong F, Witteman JCM, et al. Atherosclerosis and risk for dementia. Ann Neurol. 2007; 61: 403-410. doi:10.1002/ana.21073.
35. Watson NL, Sutton-Tyrell K, Rosano C, et al. Arterial stiffness and cognitive decline in well-functioning older adults. J GerontolMed Sci. 2011; 66A(12): 1336-1342. doi:10.1093/gerona/glr119.
36. Fillit H, Nash DT, Rundek T, et al. Cardiovascular risk factors and dementia. Ame J Geriatr Pharmacother. 2008; 6(2): 100-118. doi:10.1016/j.amjopharm.2008.06.004.
37. * Unverzagt FW, McClure LA, Wadley VG, Jenny NS, Go RC, Cushman M, Kissela, BM, Kelley BJ, Kennedy R, Moy CS, Howard V, Howard G. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurol. 2011; 77:1729–1736
38. Rastas S, Verkkoniemi A, Polvikoski T, et al. Atrial fibrillation, stroke, and cognition: A longitudinal population-based study of people aged 85 and older. Stroke. 2007; 38: 1454-1460. doi:10.1161/STROKEAHA.106.477299.
39. London GM. Left ventricular hypertrophy: Why does it happen? Nephrol Dial Transplant. 2003; 18(8): viii2-viii6. doi:10.1093/ndt/grg1083.
40. Scuteri A, Coluccia R, Castello L, et al. Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure. Eur Heart J. 2009; 30: 1525-1529. doi:10.1093/eurheartj/ehp13.
41. Elias PK, Elias MF, D’Agonstino RB, et al. Serum cholesterol and cognitive performance in the Framingham heart study. Psychosom Med. 2005; 67: 24-30. doi:10.1097/01.psy.0000151745.67285.c2.
42. Tanaka S, Tasuda T, Ishida T, et al. Increased serum cholesterol esterification rates predict coronary heart disease and sudden death in a general population. Arterioscler Thromb Vasc Biol. 2013; 33: 1098-1104.
43. * Brady CB, Spiro III A, McGlinchey-Berroth R, Milberg W, Gaziano JM. Stroke risk predicts verbal fluency decline in healthy older men: Evidence from the normative aging study. J Gerontol: Psychol Sci. 2001;56B (6):340–346
44. * Weiner MF, Hynan LS, Rossetti H, Warren MW, Cullum CM. The relationship of montreal cognitive assessment scores to Framingham coronary and stroke risk scores. Open J Psychiatry. 2011; 1:49–55
45. Kivipelto M, Ngandu T, Laatikainen T, et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: A longitudinal population-based study. Lancet Neurol. 2006; 5: 735-741. doi:10.1016/S1474-4422(06)70537-3.
46. * Jak AJ, Urban S, McCauley A, Bangen KJ, Delano-Wood L, Corey-Bloom J, Bondi MW. Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc. 2009; 15 (6):890–897. doi:10.1017/S1355617709090638
47. * Bangen KJ, Delano-Wood L, Wierenga CE, McCauley A, Jeste DV, Salmon DP, Bondi MW. Associations between stroke risk and cognition in normal aging and Alzheimer’s disease with and without depression. Int J Geriat Psychiatry. 2009; 25:175–182. doi:10.1002/gps.2317
48. Lafosse JM, Reed BR, Mungas D, et al. Fluency and memory differences between ischemic vascular dementia and Alzheimer’s disease. Neuropsychology. 1997; 11: 514-522.
49. Starkstein SE, Sabe L, Vazquez S, et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer’s disease. Stroke. 1996; 27: 408-414.
50. Wright RW, Brand RA, Dunn W, et al. How to write a systematic review. Clin Orthop Relat Res. 2007; 455: 23-29.
51. Feingold A. Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis. Psychol Methods. 2009; 14(1): 43-53. doi:10.1037/a0014699.
52. Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med. 2000; 19: 3127-3131.
53. Peterson RA, Brown SP. On the use of beta coefficients in meta-analysis. J Appl Psychol. 2005; 90(1): 175-181. doi:10.1037/0021-9010.90.1.175.
54. Rosenthal R. Meta-analytic procedures for social research. reth ed. Newbury Park: Sage; 1991.
55. Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks: Sage Publications; 2001.
56. Rosenthal R. The “file drawer problem” and tolerance for null results. Psychol Bull. 1979; 86: 638-641. doi:10.1037/0033-2909.86.3.638.
57. Kim S, Jorgensen RS, Thibodeau R. Shame, guilt, and depressive symptoms: A meta-analytic review. Psychol Bull. 2011; 137(1): 68-96. doi:10.1037/a0021466.
58. Schmidt FL, Oh IS, Hayes TL. Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. Br J Math Stat Psychol. 2009; 62(Pt 1): 97-128.
59. Rocca WA, Petersen RC, Knopman DS, et al. Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimer’s Dementia. 2011; 7(1): 80-93.
60. Ohanna I, Golander H, Barak Y. Does late onset depression predispose to dementia? A retrospective, case-controlled study. Compr Psychiatry. 2011; 52: 659-661. doi:10.1016/j.comppsych.2010.10.016.
61. Johansson L, Guo X, Waern M, et al. Midlife psychological stress and risk of dementia: a 35-year longitudinal population study. Brain. 2010; 133: 2217-2224. doi:10.1093/brain/awq116.
62. Woodruff BK, Graff-Radford NR, Ferman TJ, et al. Family history of dementia is a risk factor for Lewy body disease. Neurology. 2006; 66(12): 1949-1950.
63. Sparks DL, Kryscio RJ, Sabbagh MN, et al. Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res. 2008; 5: 416-421.
64. Gons RA, van Norden AG, de Laat KF, et al. Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter. Brain. 2011; 134(pt 7): 2216-2224. doi:10.1093/brain/awr145.
65. Berger JS, Jordan CO, Lloyd-Jones D, et al. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol. 2010; 55: 1169-1177. doi:10.1016/j.jacc/2009.09.066.
66. Vicario A, Del Sueldo M, Fernández RA, et al. Cognition and vascular risk factors: An epidemiological study. Int J Hypertens. 2012; 2012: 1-6. doi:10.1155/2012/783696.
67. * Kaffashian S, Dugravot A, Brunner EJ, Sabia S, Ankri J, Kivimaki M, Singh-Manoux A. Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort. Alzheimer’s Dement. 2013; 9:572–579. doi:10.1016/j.jalz.2012.07.001
68. * Kaffashian S, Dugravot A, Elbaz A, et al. Predicting cognitive decline: a dementia risk score vs the Framingham vascular risk scores. Neurology. 2013; 80:1300–1306. doi:10.1212/WNL.0b013e31828ab370
69. * Merrill DA, Siddarth P, Kepe V, Raja PV, Saito N, Ercoli LM, Miller KJ, Lavretsky H, Bookheimer SY, Barrio JR, Small GW. Vascular risk and FDDNP-PET influence cognitive performance. J Alzheimers Dis. 2013; 35 (1):147–157. doi:10.3233/JAD-121903
70. * Sheline YI, Barch DM, Garcia K, Gersing K, Pieper C, Welsh-Bohmer K, Steffens DC, Doraiswamy PM. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry. 2006; 60 (1):58–65
71. * Smith PJ, Blumenthal JA, Babyak MA, Hinderliter A, Sherwood A. Association of vascular health and neurocognitive performance in overweight adults with high blood pressure. J Clin Exp Neuropsychol. 2011; 33 (5):559–566